Form 4: Kyndryl CEO Martin J. Schroeter Receives Stock Grant
SEC Form 4 Filing
Kyndryl's CEO, Martin J. Schroeter, reported the acquisition of 152,059 shares of common stock on June 3, 2024, as part of a restricted stock unit grant.
Summary
- On June 3, 2024, Martin J. Schroeter, the CEO of Kyndryl Holdings, Inc., acquired 152,059 shares of common stock.
- This acquisition was a grant of Restricted Stock Units (RSUs).
- The RSUs vest in four equal installments starting on June 3, 2025.
- Following the transaction, Schroeter directly owns 1,435,739 shares of Kyndryl common stock.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management with shareholder interests. The sentiment is moderately positive as it indicates continued investment in the company by its CEO.
Positives
- The grant of RSUs to the CEO aligns his interests with the long-term performance of the company.
Industry Context
Executive compensation through stock grants is a common practice in publicly traded companies to incentivize performance and align management's interests with those of shareholders.
Stakeholder Impact
- Shareholders may view the stock grant as a positive sign, aligning the CEO's interests with the company's performance.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of transaction: Martin J. Schroeter acquired 152,059 shares of common stock. |
| 06/03/2025 | Vesting start date: Restricted Stock Units vest in four equal installments beginning on this date. |
| 06/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.